Forum Replies Created
-
AuthorPosts
-
Scarlett
Participant[quote=Vee]There The FluMist nasal spray vaccine is a weakened (attenuated) but live virus that can be spread to others. If you read the package insert, you are warned not to come into contact with anyone who may be sick or immuno-compromised for “at least 21 days.” Hospitals have quietly stopped using it for staff because it’s such a disastrous notion on its face. However, you will not be told this when you receive it.[/quote]
Well, it is true, and it was true before, for all the flu nasal mists, that they are made with live but attenuated virus, and there is a small chance of spreading THAT virus around. The hospital workers have a HIGH chance of being around a person with various illnesses or that’s immunocompromised. The chances of spreading are not high, and what is spread is the weakened virus, not the “wild” one. But those hospitals are erring on the side of safety and liability too probably. But if you receive the flumist is probably a good idea that, if you get sick in the following couple weeks, to cover your cough/sneeze and stay away from sick/immuno-compromised people. Sadly, that is rarely, if ever mentioned, I agree. (But it’s kind of common hygiene rule too).
Edit – there was something in the Flumist sheet from CDC that we got when we signed the waiver/consent for our kid
2009 H1N1 LAIV (live attenuated intranasal vaccine)should not be given to the following groups.
• children younger than 2 and adults 50 years and older
• pregnant women,
• anyone with a weakened immune system,
• anyone with a long-term health problem (…)
• anyone with certain muscle or nerve disorders (…)
• anyone in close contact with a person with a severely
weakened immune system (requiring care in a protected
environment, such as a bone marrow transplant unit),
• children or adolescents on long-term aspirin treatment.Scarlett
Participant[quote=Vee]There The FluMist nasal spray vaccine is a weakened (attenuated) but live virus that can be spread to others. If you read the package insert, you are warned not to come into contact with anyone who may be sick or immuno-compromised for “at least 21 days.” Hospitals have quietly stopped using it for staff because it’s such a disastrous notion on its face. However, you will not be told this when you receive it.[/quote]
Well, it is true, and it was true before, for all the flu nasal mists, that they are made with live but attenuated virus, and there is a small chance of spreading THAT virus around. The hospital workers have a HIGH chance of being around a person with various illnesses or that’s immunocompromised. The chances of spreading are not high, and what is spread is the weakened virus, not the “wild” one. But those hospitals are erring on the side of safety and liability too probably. But if you receive the flumist is probably a good idea that, if you get sick in the following couple weeks, to cover your cough/sneeze and stay away from sick/immuno-compromised people. Sadly, that is rarely, if ever mentioned, I agree. (But it’s kind of common hygiene rule too).
Edit – there was something in the Flumist sheet from CDC that we got when we signed the waiver/consent for our kid
2009 H1N1 LAIV (live attenuated intranasal vaccine)should not be given to the following groups.
• children younger than 2 and adults 50 years and older
• pregnant women,
• anyone with a weakened immune system,
• anyone with a long-term health problem (…)
• anyone with certain muscle or nerve disorders (…)
• anyone in close contact with a person with a severely
weakened immune system (requiring care in a protected
environment, such as a bone marrow transplant unit),
• children or adolescents on long-term aspirin treatment.Scarlett
Participant[quote=Vee]There The FluMist nasal spray vaccine is a weakened (attenuated) but live virus that can be spread to others. If you read the package insert, you are warned not to come into contact with anyone who may be sick or immuno-compromised for “at least 21 days.” Hospitals have quietly stopped using it for staff because it’s such a disastrous notion on its face. However, you will not be told this when you receive it.[/quote]
Well, it is true, and it was true before, for all the flu nasal mists, that they are made with live but attenuated virus, and there is a small chance of spreading THAT virus around. The hospital workers have a HIGH chance of being around a person with various illnesses or that’s immunocompromised. The chances of spreading are not high, and what is spread is the weakened virus, not the “wild” one. But those hospitals are erring on the side of safety and liability too probably. But if you receive the flumist is probably a good idea that, if you get sick in the following couple weeks, to cover your cough/sneeze and stay away from sick/immuno-compromised people. Sadly, that is rarely, if ever mentioned, I agree. (But it’s kind of common hygiene rule too).
Edit – there was something in the Flumist sheet from CDC that we got when we signed the waiver/consent for our kid
2009 H1N1 LAIV (live attenuated intranasal vaccine)should not be given to the following groups.
• children younger than 2 and adults 50 years and older
• pregnant women,
• anyone with a weakened immune system,
• anyone with a long-term health problem (…)
• anyone with certain muscle or nerve disorders (…)
• anyone in close contact with a person with a severely
weakened immune system (requiring care in a protected
environment, such as a bone marrow transplant unit),
• children or adolescents on long-term aspirin treatment.Scarlett
Participant[quote=Vee]There The FluMist nasal spray vaccine is a weakened (attenuated) but live virus that can be spread to others. If you read the package insert, you are warned not to come into contact with anyone who may be sick or immuno-compromised for “at least 21 days.” Hospitals have quietly stopped using it for staff because it’s such a disastrous notion on its face. However, you will not be told this when you receive it.[/quote]
Well, it is true, and it was true before, for all the flu nasal mists, that they are made with live but attenuated virus, and there is a small chance of spreading THAT virus around. The hospital workers have a HIGH chance of being around a person with various illnesses or that’s immunocompromised. The chances of spreading are not high, and what is spread is the weakened virus, not the “wild” one. But those hospitals are erring on the side of safety and liability too probably. But if you receive the flumist is probably a good idea that, if you get sick in the following couple weeks, to cover your cough/sneeze and stay away from sick/immuno-compromised people. Sadly, that is rarely, if ever mentioned, I agree. (But it’s kind of common hygiene rule too).
Edit – there was something in the Flumist sheet from CDC that we got when we signed the waiver/consent for our kid
2009 H1N1 LAIV (live attenuated intranasal vaccine)should not be given to the following groups.
• children younger than 2 and adults 50 years and older
• pregnant women,
• anyone with a weakened immune system,
• anyone with a long-term health problem (…)
• anyone with certain muscle or nerve disorders (…)
• anyone in close contact with a person with a severely
weakened immune system (requiring care in a protected
environment, such as a bone marrow transplant unit),
• children or adolescents on long-term aspirin treatment.Scarlett
Participant[quote=Vee]There The FluMist nasal spray vaccine is a weakened (attenuated) but live virus that can be spread to others. If you read the package insert, you are warned not to come into contact with anyone who may be sick or immuno-compromised for “at least 21 days.” Hospitals have quietly stopped using it for staff because it’s such a disastrous notion on its face. However, you will not be told this when you receive it.[/quote]
Well, it is true, and it was true before, for all the flu nasal mists, that they are made with live but attenuated virus, and there is a small chance of spreading THAT virus around. The hospital workers have a HIGH chance of being around a person with various illnesses or that’s immunocompromised. The chances of spreading are not high, and what is spread is the weakened virus, not the “wild” one. But those hospitals are erring on the side of safety and liability too probably. But if you receive the flumist is probably a good idea that, if you get sick in the following couple weeks, to cover your cough/sneeze and stay away from sick/immuno-compromised people. Sadly, that is rarely, if ever mentioned, I agree. (But it’s kind of common hygiene rule too).
Edit – there was something in the Flumist sheet from CDC that we got when we signed the waiver/consent for our kid
2009 H1N1 LAIV (live attenuated intranasal vaccine)should not be given to the following groups.
• children younger than 2 and adults 50 years and older
• pregnant women,
• anyone with a weakened immune system,
• anyone with a long-term health problem (…)
• anyone with certain muscle or nerve disorders (…)
• anyone in close contact with a person with a severely
weakened immune system (requiring care in a protected
environment, such as a bone marrow transplant unit),
• children or adolescents on long-term aspirin treatment.Scarlett
ParticipantI don’t think anybody said autism was a genetic epidemic, unless I missed some post? On the contrary, I believe the possible explanations presented here for the autism were linked to environmental factors,including vaccines or the mercury in some of those. Of course since not every kid gets autism,a genetic component or more precisely the interaction betweem environment and genetic makeup is what matters. That doesn’t qualify as ‘genetic epidemic’ though.
Scarlett
ParticipantI don’t think anybody said autism was a genetic epidemic, unless I missed some post? On the contrary, I believe the possible explanations presented here for the autism were linked to environmental factors,including vaccines or the mercury in some of those. Of course since not every kid gets autism,a genetic component or more precisely the interaction betweem environment and genetic makeup is what matters. That doesn’t qualify as ‘genetic epidemic’ though.
Scarlett
ParticipantI don’t think anybody said autism was a genetic epidemic, unless I missed some post? On the contrary, I believe the possible explanations presented here for the autism were linked to environmental factors,including vaccines or the mercury in some of those. Of course since not every kid gets autism,a genetic component or more precisely the interaction betweem environment and genetic makeup is what matters. That doesn’t qualify as ‘genetic epidemic’ though.
Scarlett
ParticipantI don’t think anybody said autism was a genetic epidemic, unless I missed some post? On the contrary, I believe the possible explanations presented here for the autism were linked to environmental factors,including vaccines or the mercury in some of those. Of course since not every kid gets autism,a genetic component or more precisely the interaction betweem environment and genetic makeup is what matters. That doesn’t qualify as ‘genetic epidemic’ though.
Scarlett
ParticipantI don’t think anybody said autism was a genetic epidemic, unless I missed some post? On the contrary, I believe the possible explanations presented here for the autism were linked to environmental factors,including vaccines or the mercury in some of those. Of course since not every kid gets autism,a genetic component or more precisely the interaction betweem environment and genetic makeup is what matters. That doesn’t qualify as ‘genetic epidemic’ though.
Scarlett
ParticipantFDA has posted which vaccines ever contained thimerosal.
http://www.fda.gov/biologicsbloodvaccines/safetyavailability/vaccinesafety/ucm096228#t1
http://www.fda.gov/BiologicsBloodVaccines/vaccines/QuestionsaboutVaccines/ucm070430.htm
all new vaccines for kids licensed since 1999 are free of thimerosal (except influenza).
Cessation of thimerosal use in Denmark and Sweden in 1992 prompted to conduct a before and after comparison of the incidence or case numbers of autism. In both countries, autism increases throughout the years 1987-1999, contrary to the decrease in autism that would be expected after 1992 if thimerosal exposure was related to autism. The increasing trend for autism is most notable in Denmark where the number of autism cases rises substantially even after the discontinuation of thimerosal use. The results were published in the American Journal of Preventive Medicine (Aug 2003; 25(2):101-6).
CDC has an ongoing cooperative agreement with the Danish Medical Research Council. This cooperative agreement supports a collaborative research program with Danish researchers and provides opportunities for CDC to pursue causes of birth defects and developmental disabilities through Denmark’s unique public health data infrastructure. The Danish study, which followed more than 500,000 children, over 7 years, found no association between the MMR vaccination and autism. The results were published in the New England Journal of Medicine (2002; 347:1477)
http://www.cdc.gov/vaccinesafety/00_pdf/VSD_Chart_of_Autism_Studies-Updated_Aug_18_09.pdfScarlett
ParticipantFDA has posted which vaccines ever contained thimerosal.
http://www.fda.gov/biologicsbloodvaccines/safetyavailability/vaccinesafety/ucm096228#t1
http://www.fda.gov/BiologicsBloodVaccines/vaccines/QuestionsaboutVaccines/ucm070430.htm
all new vaccines for kids licensed since 1999 are free of thimerosal (except influenza).
Cessation of thimerosal use in Denmark and Sweden in 1992 prompted to conduct a before and after comparison of the incidence or case numbers of autism. In both countries, autism increases throughout the years 1987-1999, contrary to the decrease in autism that would be expected after 1992 if thimerosal exposure was related to autism. The increasing trend for autism is most notable in Denmark where the number of autism cases rises substantially even after the discontinuation of thimerosal use. The results were published in the American Journal of Preventive Medicine (Aug 2003; 25(2):101-6).
CDC has an ongoing cooperative agreement with the Danish Medical Research Council. This cooperative agreement supports a collaborative research program with Danish researchers and provides opportunities for CDC to pursue causes of birth defects and developmental disabilities through Denmark’s unique public health data infrastructure. The Danish study, which followed more than 500,000 children, over 7 years, found no association between the MMR vaccination and autism. The results were published in the New England Journal of Medicine (2002; 347:1477)
http://www.cdc.gov/vaccinesafety/00_pdf/VSD_Chart_of_Autism_Studies-Updated_Aug_18_09.pdfScarlett
ParticipantFDA has posted which vaccines ever contained thimerosal.
http://www.fda.gov/biologicsbloodvaccines/safetyavailability/vaccinesafety/ucm096228#t1
http://www.fda.gov/BiologicsBloodVaccines/vaccines/QuestionsaboutVaccines/ucm070430.htm
all new vaccines for kids licensed since 1999 are free of thimerosal (except influenza).
Cessation of thimerosal use in Denmark and Sweden in 1992 prompted to conduct a before and after comparison of the incidence or case numbers of autism. In both countries, autism increases throughout the years 1987-1999, contrary to the decrease in autism that would be expected after 1992 if thimerosal exposure was related to autism. The increasing trend for autism is most notable in Denmark where the number of autism cases rises substantially even after the discontinuation of thimerosal use. The results were published in the American Journal of Preventive Medicine (Aug 2003; 25(2):101-6).
CDC has an ongoing cooperative agreement with the Danish Medical Research Council. This cooperative agreement supports a collaborative research program with Danish researchers and provides opportunities for CDC to pursue causes of birth defects and developmental disabilities through Denmark’s unique public health data infrastructure. The Danish study, which followed more than 500,000 children, over 7 years, found no association between the MMR vaccination and autism. The results were published in the New England Journal of Medicine (2002; 347:1477)
http://www.cdc.gov/vaccinesafety/00_pdf/VSD_Chart_of_Autism_Studies-Updated_Aug_18_09.pdfScarlett
ParticipantFDA has posted which vaccines ever contained thimerosal.
http://www.fda.gov/biologicsbloodvaccines/safetyavailability/vaccinesafety/ucm096228#t1
http://www.fda.gov/BiologicsBloodVaccines/vaccines/QuestionsaboutVaccines/ucm070430.htm
all new vaccines for kids licensed since 1999 are free of thimerosal (except influenza).
Cessation of thimerosal use in Denmark and Sweden in 1992 prompted to conduct a before and after comparison of the incidence or case numbers of autism. In both countries, autism increases throughout the years 1987-1999, contrary to the decrease in autism that would be expected after 1992 if thimerosal exposure was related to autism. The increasing trend for autism is most notable in Denmark where the number of autism cases rises substantially even after the discontinuation of thimerosal use. The results were published in the American Journal of Preventive Medicine (Aug 2003; 25(2):101-6).
CDC has an ongoing cooperative agreement with the Danish Medical Research Council. This cooperative agreement supports a collaborative research program with Danish researchers and provides opportunities for CDC to pursue causes of birth defects and developmental disabilities through Denmark’s unique public health data infrastructure. The Danish study, which followed more than 500,000 children, over 7 years, found no association between the MMR vaccination and autism. The results were published in the New England Journal of Medicine (2002; 347:1477)
http://www.cdc.gov/vaccinesafety/00_pdf/VSD_Chart_of_Autism_Studies-Updated_Aug_18_09.pdf -
AuthorPosts
